An Observational Study of Patients With Dermatologic Disease
Recruiting · NCT07748169 · Observational (researchers observe without assigning treatment) · Lead sponsor: Target PharmaSolutions, Inc.
View the official record on ClinicalTrials.gov →What this trial is about
TARGET-DERM+ is an observational research study to conduct a comprehensive review of outcomes for patients with dermatologic disease (DD) and providers who treat these patients. The study includes patients managed for DD of any etiology in usual clinical practice in the United States and addresses important clinical questions regarding the management of DD by collecting and analyzing data from patients at academic medical centers and community medical practices and/or data from providers who treat them.
Who can take part
Age range
No age limits stated
Sex
All (male and female)
Healthy volunteers
No - a diagnosis or condition is required
Phase
Not specified
Study type
Observational (researchers observe without assigning treatment)
Inclusion criteria
- Adult or pediatric participants managed for DD invited to participate OR a provider who treats patients with these conditions. Informed consent is required for all Engaged Cohort participants.
- Adult or pediatric participants at the time of enrollment with a diagnosis of DD by ICD code or other relevant healthcare code as part of the EHR interface.
Exclusion criteria
- Participant withdrew consent; Failure to complete activities as required per the cohort clarification letter.
Where it is running
3 locations listed across 3 US states.
- Wake Forest University Health Science - Winston-Salem, North Carolina, United States
- University of Pennsylvania - Philadelphia, Pennsylvania, United States
- Medical University of South Carolina - Charleston, South Carolina, United States